- Home
- NL vs HQL Comparison
NL vs HQL Comparison
Compare NL & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NL
- HQL
- Stock Information
- Founded
- NL 1891
- HQL 1992
- Country
- NL United States
- HQL United States
- Employees
- NL N/A
- HQL N/A
- Industry
- NL Major Chemicals
- HQL Investment Managers
- Sector
- NL Industrials
- HQL Finance
- Exchange
- NL Nasdaq
- HQL Nasdaq
- Market Cap
- NL 320.5M
- HQL 378.8M
- IPO Year
- NL N/A
- HQL N/A
- Fundamental
- Price
- NL $6.25
- HQL $13.99
- Analyst Decision
- NL Sell
- HQL
- Analyst Count
- NL 1
- HQL 0
- Target Price
- NL $6.00
- HQL N/A
- AVG Volume (30 Days)
- NL 24.0K
- HQL 120.9K
- Earning Date
- NL 11-05-2025
- HQL 01-01-0001
- Dividend Yield
- NL 5.79%
- HQL 11.56%
- EPS Growth
- NL 141.37
- HQL N/A
- EPS
- NL 1.10
- HQL 0.79
- Revenue
- NL $152,721,000.00
- HQL N/A
- Revenue This Year
- NL $15.75
- HQL N/A
- Revenue Next Year
- NL $2.44
- HQL N/A
- P/E Ratio
- NL $5.50
- HQL $17.08
- Revenue Growth
- NL N/A
- HQL N/A
- 52 Week Low
- NL $5.29
- HQL $11.34
- 52 Week High
- NL $9.42
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- NL 47.71
- HQL 53.25
- Support Level
- NL $6.00
- HQL $14.07
- Resistance Level
- NL $6.29
- HQL $14.30
- Average True Range (ATR)
- NL 0.25
- HQL 0.19
- MACD
- NL -0.04
- HQL -0.02
- Stochastic Oscillator
- NL 30.49
- HQL 48.00
About NL NL Industries Inc.
NL Industries Inc is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.